ProShares MSCI Transformational Changes ETF ANEW
54.66 USD -0.02 (-0.04%)
Oct 12, 2026, 9:46 AM EDT
54.66 Day range 54.66
54.66 52-week range 54.66
- YTD
- -0.05%
- 1 year
- -0.05%
News
seekingalpha.com How Policy, Geopolitics And AI Are Reshaping Markets Markets are broader than headlines suggest. AI is driving wider economic growth in Canada. Why Canada is positioned to benefit from the AI buildout.
seekingalpha.com AI's Biggest Gainers AI is everywhere in the product. But revenue growth is decelerating, from 16% to 13% to 12% guided. The productivity benefits are arriving for users and end-consumers of AI, though it's not hitting…
benzinga.com Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks WEF's 2025 Global Risks Report highlights geopolitical tensions, climate change, and disinformation as major challenges. ETFs can help investors navigate these risks with defense, clean energy, and…
prismmediawire.com ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc. Strategic Rebranding Reflects Focus on Neurodegenerative Therapies and Healthy Longevity New York, NY, September 17, 2024 – PRISM MediaWire – The Board of ANEW MEDICAL, INC. (NASDAQ: WENA), today…
globenewswire.com ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc. NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Board of ANEW MEDICAL, INC.
prismmediawire.com Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy Company will use novel, patented Klotho Gene (s-KL) in studies New York, NY, September 4, 2024 – PRISM MediaWire – ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it…
globenewswire.com Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC.
prismmediawire.com ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 – ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and…- globenewswire.com ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases,…
prismmediawire.com ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”) New York, NY. August 21, 2024 – ANEW MEDICAL, INC.
globenewswire.com ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”) NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke…
prismmediawire.com ANEW MEDICAL, INC. Appoints New CFO New York, NY, August 19, 2024 – ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.- globenewswire.com ANEW MEDICAL, INC. Appoints New CFO NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and gene-based treatments for…
prismmediawire.com ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW's IP for development and commercialization in the U.S. New York, NY, August 15, 2024 – ANEW MEDICAL, INC. (“ANEW” or…
globenewswire.com ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW's IP for development and commercialization in the U.S. Issuance of the Klotho gene-therapy patent will be…
prismmediawire.com ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides NEW YORK, NY, August 09, 2024 – ANEW MEDICAL, INC.
globenewswire.com ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides Melanocortin receptors on neurons in the brain control feeding and weight loss Patented peptide molecules delivered orally as a pill can control feeding disorders and weight loss NEW YORK, Aug. 09,…
prismmediawire.com ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and Hong Kong and awaits issuance of…
globenewswire.com ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and Hong Kong and awaits issuance of…
prismmediawire.com ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene Collaboration focuses on research and development of ANEW's patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW's mission is to deliver transformative protein,…
globenewswire.com ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene Collaboration focuses on research and development of ANEW's patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW's mission is to deliver transformative protein,…
benzinga.com EXCLUSIVE: Investing In AI? Diversify 'Beyond The Likes Of NVIDIA' Says WisdomTree's CIO Investors cannot overlook the transformative potential of AI. Thematic ETFs like WTAI provide diverse exposure to this game-changing technology.
benzinga.com COVID-19 Led To Biggest Drop In Global Carbon Emissions Environmental impact research by the Global Carbon Project suggests that global carbon emissions from greenhouse gas could fall by 2.4 billion tonnes in 2020,